Sk Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate
Sk Biopharmaceuticals Co Ltd cash flow reinvestment rate. Sk Biopharmaceuticals Co Ltd (326030) has a Cash Flow Reinvestment Rate of 0.17x as of March 2026, reinvesting ₩3.01 Billion (capex ₩2.94 Billion plus investments ₩-62.91 Million) from operating cash flow of ₩17.92 Billion. Explore 326030 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sk Biopharmaceuticals Co Ltd (2024–2025)
Cash flow reinvestment rate of Sk Biopharmaceuticals Co Ltd from 2024 to 2025. Historical reinvestment intensity for Sk Biopharmaceuticals Co Ltd across 2 annual periods. Explore Sk Biopharmaceuticals Co Ltd (326030) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Sk Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (2024–2025)
Sk Biopharmaceuticals Co Ltd cash flow reinvestment rate by year from 2024 to 2025. Year-by-year capital reinvestment analysis for Sk Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Sk Biopharmaceuticals Co Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | ₩33.88 Billion | ₩176.33 Billion | ₩29.51 Billion | ▲ +7.7% |
| 2024 | 0.18x | ₩16.93 Billion | ₩94.90 Billion | ₩13.42 Billion | — |